{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:11Z","timestamp":1792723091016,"version":"4.5.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijgc.2026.105637","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:58:48Z","timestamp":1790060328000},"page":"105637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From prolonged survival to measurable cure: defining new outcomes in advanced gynecologic cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-3906","authenticated-orcid":false,"given":"Larissa E.","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-0598","authenticated-orcid":false,"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Nogueira-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16_suppl","key":"10.1016\/j.ijgc.2026.105637_bib1","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2026.44.16_suppl.5501","article-title":"Long-term survival rates and cure modeling with dostarlimab plus chemotherapy in mismatch repair deficient\/microsatellite instability-high (dMMR\/MSI-H) primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO\/GOG-3031\/RUBY trial","volume":"44","author":"Powell","year":"2026","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.105637_bib2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41591-025-03566-1","article-title":"Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial","volume":"31","author":"Eskander","year":"2025","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ijgc.2026.105637_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.23.02132","article-title":"Durvalumab plus carboplatin\/paclitaxel followed by maintenance durvalumab with or without olaparib as first-line treatment for advanced endometrial cancer: the phase III DUO-E trial","volume":"42","author":"Westin","year":"2024","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ijgc.2026.105637_bib4","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3390\/cancers17223714","article-title":"Comparative analysis of maintenance treatments in patients with newly diagnosed advanced ovarian cancer after first-line platinum-based regimens","volume":"17","author":"Gasperoni","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ijgc.2026.105637_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2026.1924","article-title":"Long-term outcomes in patients with recurrent ovarian cancer and exceptional response to PARP inhibitors","volume":"12","author":"Haggstrom","year":"2026","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.105637_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71936","article-title":"Malignant ovarian germ cell tumor-survival and reproductive outcomes and patterns of relapse","volume":"15","author":"Dey","year":"2026","journal-title":"Cancer Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26011680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26011680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:52:55Z","timestamp":1792720375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26011680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":6,"alternative-id":["S1048891X26011680"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.105637","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From prolonged survival to measurable cure: defining new outcomes in advanced gynecologic cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.105637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105637"}}